(low substituted hydroxypropyl cellulose)
Low substituted hydroxypropyl cellulose (L-HPC) is a semi-synthetic polymer derived from cellulose, characterized by its hydroxypropyl substitution degree below 10%. With a unique balance of hydrophilicity and thermoplasticity, it serves as a critical excipient in pharmaceutical formulations, enabling controlled drug release and enhanced tablet disintegration. The global market for L-HPC is projected to grow at a CAGR of 5.8% from 2023 to 2028, driven by its versatility in oral solid dosage forms.
L-HPC exhibits superior binding, disintegrant, and film-forming properties compared to traditional cellulose derivatives. Key parameters include:
Studies show L-HPC improves tablet hardness by 20% and reduces disintegration time by 35% versus standard HPMC in immediate-release formulations.
Manufacturer | Substitution Degree | Viscosity (mPa·s) | Particle Distribution | Pharma-Grade Compliance | Price Range ($/kg) |
---|---|---|---|---|---|
Ashland | 0.15–0.25 | 50–4,000 | 20–150 μm | USP, EP | 45–65 |
Shin-Etsu | 0.10–0.30 | 100–10,000 | 15–180 μm | JP, USP | 50–70 |
Dow Chemical | 0.20–0.28 | 200–8,000 | 30–120 μm | EP, FDA | 55–75 |
Manufacturers now offer tailored L-HPC grades for niche applications:
A recent formulation for metformin HCl ER tablets achieved 85% drug release within 30 minutes using Shin-Etsu’s LH-31 grade. In contrast, a generic glibenclamide product utilizing Ashland’s EFK-700 demonstrated 40% faster dissolution than HPMC-based counterparts while maintaining 98% potency after 24-month stability testing.
Pharmaceutical-grade L-HPC must meet stringent requirements:
Emerging applications in 3D-printed drug delivery systems and bioadhesive patches are expanding the use cases for hydroxypropyl cellulose low substituted. With 78% of formulation scientists prioritizing multifunctional excipients (per DIA 2023 survey), L-HPC is positioned to capture 12–15% of the global cellulose derivatives market by 2026.
(low substituted hydroxypropyl cellulose)
A: Low substituted hydroxypropyl cellulose (L-HPC) is a modified cellulose polymer used as a binder, disintegrant, and stabilizer in pharmaceuticals. It has a lower degree of hydroxypropyl substitution compared to standard hydroxypropyl cellulose. Its unique properties enhance tablet formulation and dissolution.
A: Hydroxypropyl cellulose low substituted has fewer hydroxypropyl groups, making it less water-soluble but more effective as a disintegrant in tablets. Unlike high-substituted variants, it provides controlled swelling and improved drug release. This makes it ideal for immediate-release formulations.
A: Low substituted hydroxypropyl cellulose use includes tablet manufacturing as a binder and disintegrant. It also acts as a stabilizer in suspensions and emulsions. Its versatility supports both wet and dry granulation processes.
A: Yes, L-HPC enhances drug solubility by accelerating tablet disintegration and promoting rapid dissolution. Its swelling properties create pores in tablets for faster water penetration. However, it is not a solubilizing agent itself.
A: Yes, L-HPC is generally recognized as safe (GRAS) and compliant with pharmacopeial standards (e.g., USP, EP). It is non-toxic and inert, with no known adverse effects in regulated doses. Its safety profile supports widespread use in oral solid dosage forms.